[Adult-to-adult living donor liver transplantation using right lobe including middle hepatic vein].
OBJECTIVE
To investigate the feasibility and the clinical efficacy of right lobe including middle hepatic vein in adult-to-adult living donor liver transplantation.


METHODS
We retrospectively analyzed the clinical data of 30 adult-to-adult living donor liver transplantation using right lobe including middle hepatic vein performed in our hospital from Feb. 2007 to Nov. 2007.


RESULTS
The right lobes weighed 540-1058 g (median 708 g). The remnant liver volumes were over 30% of the total liver volume in all donors. No perioperative death was noted for among donors and recipients. Complications were recorded and cured in 4 donors (13.3%) and 7 recipients (23.3%). All the donors and the recipients were followed up for 2-8 months (median 5 months), during which no donor died and 1 recipient died from aspergillus infection 4 months after operation.


CONCLUSIONS
Adult-to-adult living donor liver transplantation using right lobe graft including middle hepatic vein is a safe and effective technique.
Shen
Zhong-yang
ZY
Tianjin First Central Hospital, Tianjin 300192, China. shenzy@ootc.com
Jiang
Wen-tao
WT
Zhu
Zhi-jun
ZJ
Pan
Cheng
C
Deng
Yong-lin
YL
Zheng
Hong
H
Wang
Hong-hai
HH
Li
Jun-jie
JJ
D000328:Adult; D000368:Aged; D005260:Female; D006503:Hepatic Veins / Q000601:surgery / Q000637:transplantation*; D006801:Humans; D008099:Liver / Q000098:blood supply* / Q000601:surgery; D016031:Liver Transplantation / Q000009:adverse effects; D019520:Living Donors; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000209:etiology; D012189:Retrospective Studies; D014184:Transplantation, Homologous / Q000009:adverse effects